American Association for the Advancement of Science, Science Immunology, 84(8), 2023
DOI: 10.1126/sciimmunol.adi8764
Full text: Unavailable
Passive immunization with nirsevimab protects infants from severe RSV disease without impairing the immune response to natural infection.